ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $19,387,306 | -58.8% | 1,131,775 | -53.0% | 0.44% | -54.0% |
| Q4 2022 | $47,107,906 | +40.1% | 2,407,149 | +14.2% | 0.96% | +33.2% |
| Q3 2022 | $33,630,000 | +16.0% | 2,107,149 | 0.0% | 0.72% | -7.2% |
| Q2 2022 | $28,994,000 | -13.2% | 2,107,149 | 0.0% | 0.77% | +6.0% |
| Q1 2022 | $33,419,000 | -27.3% | 2,107,149 | 0.0% | 0.73% | -10.1% |
| Q4 2021 | $45,999,000 | -27.0% | 2,107,149 | 0.0% | 0.81% | -7.1% |
| Q3 2021 | $62,983,000 | -32.5% | 2,107,149 | 0.0% | 0.87% | -41.7% |
| Q2 2021 | $93,326,000 | -0.2% | 2,107,149 | 0.0% | 1.50% | +6.2% |
| Q1 2021 | $93,494,000 | -20.2% | 2,107,149 | -1.4% | 1.41% | -13.9% |
| Q4 2020 | $117,143,000 | – | 2,136,081 | – | 1.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |